CEA and CA 549 in serum and pleural fluid of patients with pleural effusion

Lung Cancer

Volumn 36, Issue 1, 2002, Pages 83-89

  Hernández, Luis ^a   Espasa, Antonia ^a   Fernández, Cleofé ^a   Candela, Alfredo ^a   Martín, Concepción ^a   Romero, Santiago ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Adenocarcinoma; CA 549; CEA; Lung cancer; Malignant pleural effusion; Tumour markers

Indexed keywords

CARBOHYDRATE ANTIGEN; CARBOHYDRATE ANTIGEN 549; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; OVARY TUMOR; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; SCHOOL CHILD; THORACOCENTESIS;

EID: 0036124791     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00474-3     Document Type: Article

References (22)

1. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients
2. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions
3. Pretreatment evaluation of non-small cell lung cancer
4. Recommandations concernant l'utilisation des marqueurs tumoraux sériques dans la prise en charge des cancers bronchiques primitifs
5. Serum levels and biochemical characteristics of cancer-associated antigen CA 549, a circulating breast cancer marker
6. CA 549: Immunohistochemistry and serum levels in breast carcinoma and other neoplasms
7. Serum levels of cancer-associated antigen CA 549 in patients with advanced breast cancer
8. Breast cancer marker CA 549: A multicenter study
9. Clinical utility and validation of emerging biochemical markers for mammary adenocarcinoma
10. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
11. Management of malignant pleural effusions
12. Serum tumour markers in lung cancer: History, biology and clinical applications
13. Serum CA 549 in primary breast cancer: Comparison with CA 15.3 and MCA
14. A new biomarker in monitoring breast cancer: CA 549
15. Evaluation of the circulating glycoprotein CA 549 in mammary cancer and other malignancies
16. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer
17. Clinical value of CA 125, CA 19-9, CEA, CA 72-4 and TPA in borderline ovarian tumor
18. Results of a nationwide proficiency test for carcinoembryonic antigen
19. Carcinoembryonic antigen
20. Elevated level of carcinoembryonic antigen in nonmalignant pleural effusions
21. Pleural effusion in lung cancer
22. The significance of cytologically negative pleural effusion in bronchogenic carcinoma